Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C FISHER

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|May 19, 2023
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasmsTim Kong, LaYow Yu, Angelo B A Laranjeira, et al.
Experimental Hematology|August 23, 2023
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in miceDaniel A C Fisher, Angelo B A Laranjeira, Tim Kong, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
Development of a blood urea monitoring system for the closed loop control of dialysisP T Smirthwaite, A C Fisher, I A Henderson, et al.
Optics Express|June 12, 2009
Application of frequency-domain Fluorescence Lifetime Imaging Microscopy as a quantitative analytical tool for microfluidic devicesA D Elder, S M Matthews, J Swartling, et al.
Blood|March 8, 2024
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasmsAngelo B A Laranjeira, Tim Kong, Steven C Snyder, et al.
Experimental Hematology|April 3, 2022
Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromesLuana Chiquetto Paracatu, Darlene A Monlish, Zev J Greenberg, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 24, 1999
Monocular and binocular depth discrimination thresholdsS B Kaye, A Siddiqui, A Ward, et al.
British Journal of Haematology|February 7, 2022
Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinibAmy Zhou, Tim Kong, Jared S Fowles, et al.
Leukemia|February 6, 2019
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signalingDaniel A C Fisher, Cathrine A Miner, Elizabeth K Engle, et al.
Experimental Hematology|February 10, 2024
Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasmsTaylor B Collins, Angelo B A Laranjeira, Tim Kong, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|May 19, 2023
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasmsTim Kong, LaYow Yu, Angelo B A Laranjeira, et al.
Experimental Hematology|August 23, 2023
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in miceDaniel A C Fisher, Angelo B A Laranjeira, Tim Kong, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
Development of a blood urea monitoring system for the closed loop control of dialysisP T Smirthwaite, A C Fisher, I A Henderson, et al.
Optics Express|June 12, 2009
Application of frequency-domain Fluorescence Lifetime Imaging Microscopy as a quantitative analytical tool for microfluidic devicesA D Elder, S M Matthews, J Swartling, et al.
Blood|March 8, 2024
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasmsAngelo B A Laranjeira, Tim Kong, Steven C Snyder, et al.
Experimental Hematology|April 3, 2022
Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromesLuana Chiquetto Paracatu, Darlene A Monlish, Zev J Greenberg, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 24, 1999
Monocular and binocular depth discrimination thresholdsS B Kaye, A Siddiqui, A Ward, et al.
British Journal of Haematology|February 7, 2022
Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinibAmy Zhou, Tim Kong, Jared S Fowles, et al.
Leukemia|February 6, 2019
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signalingDaniel A C Fisher, Cathrine A Miner, Elizabeth K Engle, et al.
Experimental Hematology|February 10, 2024
Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasmsTaylor B Collins, Angelo B A Laranjeira, Tim Kong, et al.
Pageof 10